Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-2021015
  • Global CRISPR Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: May 2017 | Report Code: HBI-2021015

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is an RNA guided gene editing system that uses bacterially derived protein (Cas9) and a synthetic guided RNA to introduce a double strand brake at a particular location within the genome. Through this method, bacteria capture short sequences of nucleic acid from invading pathogens and combine them in CRISPR loci amidst the repeats. Small RNA’s produced by transcription of CRISPR loci, guides a set of bacterial endonucleases to split the genomes of invading pathogens. This system has been adopted as a powerful technique enabling genome editing into the mainstream. The Global CRISPR Market is expected to have a CAGR of 36.2%% for the forecast period of 2016-2023.Technological advancement is the key driver for global CRISPR market. Moreover, rise in the drug discovery market, increasing demand for synthetic genes, rising age related genetic disorders and rise in the healthcare research & development budgets are also fuelling the global CRISPR market. However, limited awareness and ethical issues are restraining factors of the global CRISPR market.

The gene editing technology has grown significantly in the last decade as the gene editing tools have become more accessible and cost effective which has enabled a thorough understanding of human genome. CRISPR (clustered regularly interspaced short palindromic repeats) is a new gene editing tool which has opened new doors for gene editing. This technology allows researchers to perform microsurgery on genes, precisely and easily, changing a DNA sequence at exact locations on a chromosome. CRISPR market is expected to grow due to drivers such as increased R&D expenditure on biotechnology, backed by venture capitals, increasing age related genetic disorders, increasing private and government expenditure on genetic research, high prevalence rate of genetic birth disorders and high demand of synthetic genes. Several factors such as limited awareness and little presence in emerging markets are restraints in the path of growth of the market.

 

Source: OBRC Analysis.

Increasing demand for synthetic genes- with the discovery of the CRISPR-CAS9 system from streptococcus pyogenes, genome editing has been revolutionized. CRISPR (clustered regularly interspaced short palindromic repeat) is an RNA guided gene editing system that uses bacterially derived protein (Cas9) and a synthetic guided RNA to introduce a double strand brake at a particular location within the genome. Through this method, bacteria capture short sequences of nucleic acid from invading pathogens and combine them in CRISPR loci amidst the repeats. Small RNA’s which are produced by transcription of CRISPR loci, guides a set of bacterial endonucleases to split the genomes of invading pathogens. This system has been adopted as a powerful technique enabling genome editing into the mainstream.

Gene editing is done by transfecting a cell with Cas9 protein along with guided RNA (Grna) that directs hybridization with its matching genomic sequence. CRISPR is good particularly for the efficient generation of complete knockout of genes on multiple alleles. 

The report on global CRISPR market includes segmentation on the basis of application and end-user.

Application is sub segmented into:

  • Genome Editing
  • Genetic Engineering
  • Grna Database/Gene Library
  • Crispr Plasmid
  • Human Stem Cells
  • Genetically Modified Organisms/Crops
  • Cell Line Engineering








End-user is sub segmented into:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research and Development Institutes





The revenue for the above application and end-user segments are specific to global CRISPR market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report.

The global CRISPR market report is geographically segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





The Global CRISPR market is segmented on the basis of application and end users. On the basis of application the market is further segmented into Genome Editing, Genetic engineering, gRNA Database/Gene Library, CRISPR Plasmid and vectors so on. CRISPR Plasmid is the highest growing segment due to high demand among scientists and researchers. By end user, the market is segmented into Biotechnology companies, Pharmaceutical companies, Academic and research Institutes, Research and development institutes, Competitive Intelligence, Merger and Acquisitions and Innovation. In end user, academic and research is the highest growing segment due to high level of R&D into genome process, development of new drugs and development of genetically modified organisms and drugs.

The geography analysis consists of North America (US, Canada), Europe (United Kingdom, France, Germany, Spain, Italy), Asia Pacific (India, China, Japan) and Rest of the world. North America was the largest geographical market (2015) in CRISPR due to high level of academies and research based in region. Asia-Pacific is expected to grow at the fastest rate in forecast period due to increase in number of contract research organization and emergence of drug discovery.

The major market players of the global CRISPR market are:

  • CARIBOU BIOSCIENCES
  • CELLECTIS
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • HORIZON DISCOVERY PLC
  • OTHERS







These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the CRISPR market.

For Example; On October 8, 2015, DuPont and Caribou Bioscience entered into a multiyear research collaboration to develop the genome editing technology platform. Caribou is a leading CRISPR Cas technology developer for genome editing. As per the agreement, the companies provided license to each other for the development of their corresponding exclusive portfolios. However, the amount involved in the agreement was not disclosed by both the companies. The cross license permitted Caribou to advance and exploit CRISPR-Cas technology for the new product development in field such as diagnostics, human and animal therapeutics, research tools, agriculture segments and industrial biotechnology. DuPont license is exclusively given by Vilnius University for the Cas9-medicated genome editing, an intellectual property right owned by Vilnius University.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis for global CRISPR market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as end-user and applications of CRISPR.
  • Identify and understand the strengths, opportunities, challenges and threat of the CRISPR market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of voice communication segment market.
  • Detailed analysis of various regulatory policies which affect the global CRISPR market.






How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global CRISPR market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the CRISPR market, with giving extensive SCOT analysisof key companies. 

Key findings of the global CRISPR market:

  • North America held highest revenue share in 2016.
  • CRISPR Plasmid is the fastest growing segment due to high demand among scientists and researchers
  • Acquisition is the key strategy adopted by players of CRISPR market.
  • In end user, the academic and research has the highest growth rate.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

 

2.       MARKET OVERVIEW

2.1. GLOBAL CRISPR MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360 DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

3.       MARKET DETERMINANTS 

3.1. MARKET DRIVERS

3.1.1.        AGE RELATED GENETIC DISORDERS

3.1.2.        DEMAND FOR SYNTHETIC GENES

3.1.3.        GLOBAL INCREASE IN LIFE STYLE ORIENTED DISEASES & FATALITIES

3.1.4.        GMOS INCREASE CROP YIELDS AND PROMOTE EFFICIENT LAND USE

3.1.5.        HIGH PREVALENCE OF GENETIC BIRTH DISORDERS

3.1.6.        RISE IN DRUG DISCOVERY MARKET

3.1.7.        RISE IN THE HEALTHCARE RESEARCH AND DEVELOPMENT BUDGETS

3.2. MARKET RESTRAINTS

3.2.1.        ETHICAL ISSUES RELATED TO MISUSE OF CRISPR GENE EDITING TOOL

3.2.2.        LIMITED AWARENESS

3.2.3.        LIMITED PRESENCE IN EMERGING MARKETS

3.3. MARKET OPPORTUNITIES

3.3.1.        CRISPR GENE EDITING CAN OPEN THE MARKET FOR GENE SURGERY.

3.3.2.        EMERGING CONTRACT RESEARCH MARKET IN ASIA

3.4. MARKET CHALLENGES 

3.4.1.        PATENT INFRINGEMENT

3.4.2.        PRESENCE OF ALTERNATIVE GENE EDITING TOOLS

 

4.       GLOBAL CRISPR MARKET BY APPLICATION

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT 

4.3. DATABASE & ESTIMATION METHODOLOGY

4.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.5. OPPORTUNITY MATRIX

4.6. MARKET SEGMENTATION 

4.6.1.        GLOBAL CRISPR IN CELL LINE ENGINEERING MARKET

4.6.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.1.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.1.4.  KEY CONCLUSIONS

4.6.2.        GLOBAL CRISPR in CRISPR PLASMID MARKET

4.6.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.2.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.2.4.  KEY CONCLUSIONS

4.6.3.        GLOBAL CRISPR in  GENETIC ENGINEERING MARKET

4.6.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.3.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.3.4.  KEY CONCLUSIONS

4.6.4.        GLOBAL CRISPR in  GENETICALLY MODIFIED ORGANISMS/CROPS MARKET

4.6.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.4.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.4.4.  KEY CONCLUSIONS

4.6.5.        GLOBAL CRISPR in  GENOME EDITING MARKET

4.6.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.5.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.5.4.  KEY CONCLUSIONS

4.6.6.        GLOBAL CRISPR in GRNA DATABASE/GENE LIBRARY MARKET

4.6.6.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.6.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.6.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.6.4.  KEY CONCLUSIONS

4.6.7.        GLOBAL CRISPR in  HUMAN STEM CELLS MARKET

4.6.7.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.7.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.7.3.  KEY PLAYERS & KEY PRODUCTS 

4.6.7.4.  KEY CONCLUSIONS

 

5.       GLOBAL CRISPR MARKET BY END USER

5.1.1.        MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4. OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION 

5.5.1.        GLOBAL CRISPR IN ACADEMIC INSTITUTES MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS & KEY PRODUCTS 

5.5.1.4.  KEY CONCLUSIONS

5.5.2.        GLOBAL CRISPR IN BIOTECHNOLOGY COMPANIES MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS & KEY PRODUCTS 

5.5.2.4.  KEY CONCLUSIONS

5.5.3.        GLOBAL CRISPR IN PHARMACEUTICAL COMPANIES MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  KEY PLAYERS & KEY PRODUCTS 

5.5.3.4.  KEY CONCLUSIONS

5.5.4.        GLOBAL CRISPR IN RESEARCH AND DEVELOPMENT INSTITUTES MARKET

5.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.4.3.  KEY PLAYERS & KEY PRODUCTS 

5.5.4.4.  KEY CONCLUSIONS

 

6.       COMPETITIVE LANDSCAPE

6.1. KEY STRATEGIES

6.1.1.        LIST OF MERGERS & ACQUISITION 

6.1.2.        LIST OF JOINT VENTURES

6.1.3.        LIST OF PRODUCT LAUNCHES

6.1.4.        LIST OF PARTNERSHIPS

 

7.       GEOGRAPHICAL ANALYSIS

7.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.3. OPPORTUNITY MATRIX

7.4. GLOBAL CRISPR MARKET BY REGION 2015-2024 ($ MILLION)

7.4.1.        NORTH AMERICA

7.4.1.1.  INDUSTRIAL END-USER ANALYSIS 2015-2024 ($ MILLION)

7.4.1.2.  TOP COUNTRY ANALYSIS

7.4.1.2.1.        U.S. 

7.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.1.2.1.3.   KEY CONCLUSIONS

7.4.1.2.2.        CANADA

7.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.1.2.2.3.   KEY CONCLUSIONS

7.4.2.        EUROPE

7.4.2.1.  INDUSTRY END-USER ANALYSIS 2015-2024 ($ MILLION)

7.4.2.2.  TOP COUNTRY ANALYSIS

7.4.2.2.1.        UK

7.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.1.3.   KEY CONCLUSIONS

7.4.2.2.2.        FRANCE

7.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.2.3.   KEY CONCLUSIONS

7.4.2.2.3.        GERMANY

7.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.3.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.3.3.   KEY CONCLUSIONS

7.4.2.2.4.        SPAIN

7.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.4.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.4.3.   KEY CONCLUSIONS

7.4.2.2.5.        REST OF EUROPE

7.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.5.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.5.3.   KEY CONCLUSIONS

7.4.3.        ASIA PACIFIC

7.4.3.1.  INDUSTRY END-USER ANALYSIS 2015-2024 ($ MILLION)

7.4.3.2.  TOP COUNTRY ANALYSIS

7.4.3.2.1.        CHINA

7.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.1.3.   KEY CONCLUSIONS

7.4.3.2.2.        INDIA

7.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.2.3.   KEY CONCLUSIONS

7.4.3.2.3.        JAPAN

7.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.3.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.3.3.   KEY CONCLUSIONS

7.4.3.2.4.        AUSTRALIA

7.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.4.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.4.3.   KEY CONCLUSIONS

7.4.3.2.5.        REST OF ASIA PACIFIC

7.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.5.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.5.3.   KEY CONCLUSIONS

7.4.4.        ROW

7.4.4.1.  INDUSTRY END-USER ANALYSIS 2015-2024 ($ MILLION)

7.4.4.2.  TOP COUNTRY ANALYSIS

7.4.4.2.1.        LATIN AMERICA

7.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.4.2.1.3.   KEY CONCLUSIONS

7.4.4.2.2.        MIDDLE EAST & AFRICA 

7.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.4.2.2.3.   KEY CONCLUSIONS

 

8.       COMPANY PROFILES

8.1. CARIBOU BIOSCIENCES

8.1.1.        OVERVIEW

8.1.2.        PRODUCT PORTFOLIO

8.1.3.        STRATEGIC INITIATIVES 

8.1.4.        SCOT ANALYSIS

8.1.5.        STRATEGIC ANALYSIS

8.2. CELLECTIS

8.2.1.        OVERVIEW

8.2.2.        PRODUCT PORTFOLIO

8.2.3.        STRATEGIC INITIATIVES 

8.2.4.        SCOT ANALYSIS 

8.2.5.        STRATEGIC ANALYSIS

8.3. CRISPR THERAPEUTICS

8.3.1.        OVERVIEW

8.3.2.        PRODUCT PORTFOLIO

8.3.3.        STRATEGIC INITIATIVES 

8.3.4.        SCOT ANALYSIS

8.3.5.        STRATEGIC ANALYSIS

8.4. EDITAS MEDICINE 

8.4.1.        OVERVIEW

8.4.2.        PRODUCT PORTFOLIO

8.4.3.        STRATEGIC INITIATIVES 

8.4.4.        SCOT ANALYSIS

8.4.5.        STRATEGIC ANALYSIS

8.5. GENSCRIPT

8.5.1.        OVERVIEW

8.5.2.        PRODUCT PORTFOLIO

8.5.3.        STRATEGIC INITIATIVES 

8.5.4.        SCOT ANALYSIS 

8.5.5.        STRATEGIC ANALYSIS

8.6. HORIZON DISCOVERY PLC

8.6.1.        OVERVIEW

8.6.2.        PRODUCT PORTFOLIO

8.6.3.        STRATEGIC INITIATIVES 

8.6.4.        SCOT ANALYSIS 

8.6.5.        STRATEGIC ANALYSIS

8.7. INTEGRATED DNA TECHNOLOGIES

8.7.1.        OVERVIEW

8.7.2.        PRODUCT PORTFOLIO

8.7.3.        STRATEGIC INITIATIVES 

8.7.4.        SCOT ANALYSIS 

8.7.5.        STRATEGIC ANALYSIS

8.8. INTELLIA THERAPEUTICS, INC.

8.8.1.        OVERVIEW

8.8.2.        PRODUCT PORTFOLIO

8.8.3.        STRATEGIC INITIATIVES 

8.8.4.        SCOT ANALYSIS 

8.8.5.        STRATEGIC ANALYSIS

8.9. LONZA GROUP LIMITED

8.9.1.        OVERVIEW

8.9.2.        PRODUCT PORTFOLIO

8.9.3.        STRATEGIC INITIATIVES 

8.9.4.        SCOT ANALYSIS 

8.9.5.        STRATEGIC ANALYSIS

8.10.              NEW ENGLAND BIOLABS

8.10.1.   OVERVIEW

8.10.2.   PRODUCT PORTFOLIO

8.10.3.   STRATEGIC INITIATIVES 

8.10.4.   SCOT ANALYSIS

8.10.5.   STRATEGIC ANALYSIS

8.11.              OREGENE TECHNOLOGIES

8.11.1.   OVERVIEW

8.11.2.   PRODUCT PORTFOLIO

8.11.3.   STRATEGIC INITIATIVES 

8.11.4.   SCOT ANALYSIS

8.11.5.   STRATEGIC ANALYSIS

8.12.              PRECISION BIOSCIENCES

8.12.1.   OVERVIEW

8.12.2.   PRODUCT PORTFOLIO

8.12.3.   STRATEGIC INITIATIVES 

8.12.4.   SCOT ANALYSIS

8.12.5.   STRATEGIC ANALYSIS

8.13.              SANGAMO BIOSCIENCES INC.

8.13.1.   OVERVIEW

8.13.2.   PRODUCT PORTFOLIO

8.13.3.   STRATEGIC INITIATIVES 

8.13.4.   SCOT ANALYSIS

8.13.5.   STRATEGIC ANALYSIS

8.14.              SIGMA ALDRICH

8.14.1.   OVERVIEW

8.14.2.   PRODUCT PORTFOLIO

8.14.3.   STRATEGIC INITIATIVES 

8.14.4.   SCOT ANALYSIS

8.14.5.   STRATEGIC ANALYSIS

8.15.              THERMO FISHER SCIENTIFIC, INC.

8.15.1.   OVERVIEW

8.15.2.   PRODUCT PORTFOLIO

8.15.3.   STRATEGIC INITIATIVES 

8.15.4.   SCOT ANALYSIS

8.15.5.   STRATEGIC ANALYSIS

 

1.       LIST OF TABLES

 

1.       GLOBAL CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

2.       GLOBAL CRISPR IN CELL LINE ENGINEERING MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL CRISPR IN CRISPR PLASMID MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL CRISPR IN GENETIC ENGINEERING MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL CRISPR IN GENOME EDITING MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL CRISPR IN HUMAN STEM CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

10.   GLOBAL CRISPR IN ACADEMIC INSTITUTES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL CRISPR IN BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL CRISPR IN PHARMACEUTICAL COMPANIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL CRISPR IN RESEARCH AND DEVELOPMENT INSTITUTES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   NORTH AMERICA CRISPR MARKET 2015-2024 ($ MILLION)

15.   EUROPE CRISPR MARKET 2015-2024 ($ MILLION)

16.   ASIA PACIFIC CRISPR MARKET 2015-2024 ($ MILLION)

17.   REST OF THE WORLD CRISPR MARKET 2015-2024 ($ MILLION)

18.   NORTH AMERICA CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

19.   NORTH AMERICA CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

20.   EUROPE CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

21.   EUROPE CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

22.   ASIA PACIFIC CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

23.   ASIA PACIFIC CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

24.   ROW CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

25.   ROW CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

26.   United States CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.   United States CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

28.   Canada CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

29.   Canada CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

30.   UK CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

31.   UKCRISPR MARKET BY END USER 2015-2024 ($ MILLION)

32.   Germany CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

33.   Germany CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

34.   France CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

35.   France CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

36.   Spain CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

37.   Spain CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

38.   ROE CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

39.   ROE CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

40.   China CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

41.   China CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

42.   India CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

43.   India CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

44.   Japan CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

45.   Japan CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

46.   Australia CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

47.   Australia CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

48.   ROAPAC CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

49.   ROAPAC CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

50.   Latin America CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

51.   Latin America CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

52.   MENA CRISPR MARKET BY APPLICATION 2015-2024 ($ MILLION)

53.   Mena CRISPR MARKET BY END USER 2015-2024 ($ MILLION)

54.   North America CRISPR IN CELL LINE ENGINEERING MARKET BY country 2015-2024 ($ MILLION)

55.   North America CRISPR IN CRISPR PLASMID MARKET BY Country 2015-2024 ($ MILLION)

56.   North America CRISPR IN GENETIC ENGINEERING MARKET BY Country 2015-2024 ($ MILLION)

57.   North America CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET BY Country 2015-2024 ($ MILLION)

58.   North America CRISPR IN GENOME EDITING MARKET BY Country 2015-2024 ($ MILLION)

59.   North America CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET BY Country 2015-2024 ($ MILLION)

60.   North America CRISPR IN HUMAN STEM CELLS MARKET BY Country 2015-2024 ($ MILLION)

61.   Asia Pacific CRISPR IN CELL LINE ENGINEERING MARKET BY country 2015-2024 ($ MILLION)

62.   Asia Pacific CRISPR IN CRISPR PLASMID MARKET BY Country 2015-2024 ($ MILLION)

63.   Asia Pacific CRISPR IN GENETIC ENGINEERING MARKET BY Country 2015-2024 ($ MILLION)

64.   Asia Pacific CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET BY Country 2015-2024 ($ MILLION)

65.   Asia Pacific CRISPR IN GENOME EDITING MARKET BY Country 2015-2024 ($ MILLION)

66.   Asia Pacific CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET BY Country 2015-2024 ($ MILLION)

67.   Asia Pacific CRISPR IN HUMAN STEM CELLS MARKET BY Country 2015-2024 ($ MILLION)

68.   Europe CRISPR IN CELL LINE ENGINEERING MARKET BY country 2015-2024 ($ MILLION)

69.   Europe CRISPR IN CRISPR PLASMID MARKET BY Country 2015-2024 ($ MILLION)

70.   Europe CRISPR IN GENETIC ENGINEERING MARKET BY Country 2015-2024 ($ MILLION)

71.   Europe CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET BY Country 2015-2024 ($ MILLION)

72.   Europe CRISPR IN GENOME EDITING MARKET BY Country 2015-2024 ($ MILLION)

73.   Europe CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET BY Country 2015-2024 ($ MILLION)

74.   Europe CRISPR IN HUMAN STEM CELLS MARKET BY Country 2015-2024 ($ MILLION)

75.   ROW CRISPR IN CELL LINE ENGINEERING MARKET BY country 2015-2024 ($ MILLION)

76.   ROW CRISPR IN CRISPR PLASMID MARKET BY Country 2015-2024 ($ MILLION)

77.   ROW CRISPR IN GENETIC ENGINEERING MARKET BY Country 2015-2024 ($ MILLION)

78.   ROW CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET BY Country 2015-2024 ($ MILLION)

79.   ROW CRISPR IN GENOME EDITING MARKET BY Country 2015-2024 ($ MILLION)

80.   ROW CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET BY Country 2015-2024 ($ MILLION)

81.   ROW CRISPR IN HUMAN STEM CELLS MARKET BY Country 2015-2024 ($ MILLION)

 

2.       LIST OF FIGURES

 

1.       GLOBAL CRISPR IN CELL LINE ENGINEERING MARKET 2015-2024 ($ MILLION)

2.       GLOBAL CRISPR IN CRISPR PLASMID MARKET 2015-2024 ($ MILLION)

3.       GLOBAL CRISPR IN GENETIC ENGINEERING MARKET 2015-2024 ($ MILLION)

4.       GLOBAL CRISPR IN GENETICALLY MODIFIED ORGANISMS/CROPS MARKET 2015-2024 ($ MILLION)

5.       GLOBAL CRISPR IN GENOME EDITING MARKET 2015-2024 ($ MILLION)

6.       GLOBAL CRISPR IN GRNA DATABASE/GENE LIBRARY MARKET 2015-2024 ($ MILLION)

7.       GLOBAL CRISPR IN HUMAN STEM CELLS MARKET 2015-2024 ($ MILLION)

8.       GLOBAL CRISPR IN ACADEMIC INSTITUTES MARKET 2015-2024 ($ MILLION)

9.       GLOBAL CRISPR IN BIOTECHNOLOGY COMPANIES MARKET 2015-2024 ($ MILLION)

10.   GLOBAL CRISPR IN PHARMACEUTICAL COMPANIES MARKET 2015-2024 ($ MILLION)

11.   GLOBAL CRISPR IN RESEARCH AND DEVELOPMENT INSTITUTES MARKET 2015-2024 ($ MILLION)

12.   UNITED STATES (U.S.) CRISPR MARKET 2015-2024 ($ MILLION)

13.   CANADA CRISPR MARKET 2015-2024 ($ MILLION)

14.   UNITED KINGDOM (UK) CRISPR MARKET 2015-2024 ($ MILLION)

15.   FRANCE CRISPR MARKET 2015-2024 ($ MILLION)

16.   GERMANY CRISPR MARKET 2015-2024 ($ MILLION)

17.   SPAIN CRISPR MARKET 2015-2024 ($ MILLION)

18.   ROE CRISPR MARKET 2015-2024 ($ MILLION)

19.   INDIA CRISPR MARKET 2015-2024 ($ MILLION)

20.   CHINA CRISPR MARKET 2015-2024 ($ MILLION)

21.   JAPAN CRISPR MARKET 2015-2024 ($ MILLION)

22.   AUSTRALIA CRISPR MARKET 2015-2024 ($ MILLION)

23.   ROAPAC CRISPR MARKET 2015-2024 ($ MILLION)

24.   LATIN AMERICA CRISPR MARKET 2015-2024 ($ MILLION)

25.   MENA CRISPR MARKET 2015-2024 ($ MILLION)

 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion